UTERINE SARCOMA: EXPERIENCE AND OUTCOME FROM A TERTIARY CARE RURAL CANCER CENTER
Keywords:
RURAL CENTER, UTERINE SARCOMAAbstract
AIM: This is a retrospective study of clinical profile and outcomes of uterine sarcomas presenting to a tertiary cancer center in rural Punjab.
Background: All Uterine sarcomas (US) excluding carcinosarcoma registered at our center from 2015 to 2019 were included in the analysis.
Case description: A total of 16 cases of US were diagnosed and treated. Amongst them seven patients were endometrial stromal sarcoma, 6 were leiomyosarcoma and 3 were undifferentiated uterine sarcoma. Most patients presented with per vaginal bleeding and pelvic pain. Total 9 patients died out of 16.
Conclusion: Uterine sarcomas are rare tumors, which presents with advance disease and recurrence in follow up period.
Keywords: Rural center, Uterine sarcoma
References
Tropé CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012 Jul;51(6):694-705. doi: 10.3109/0284186X.2012.689111. PMID: 22793037.
Mourits MJ, De Vries EG, Willemse PH, Ten Hoor KA, Hollema H, Van der Zee AG. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol. 2001 May;97(5 Pt 2):855-66. doi: 10.1016/s0029-7844(00)01196-0. PMID: 11336777.
Almeida TG, Cunha IW, Maciel GAR, Baracat EC, Carvalho KC. Clinical and molecular features of uterine sarcomas. MEDICALEXPRESS 2014;1(6):291-297 http://www.dx.doi.org/10.5935/MedicalExpress.2014.06.02
Oliva E. Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations. Int J Gynecol Pathol. 2014 Jul;33(4):374-84. doi: 10.1097/PGP.0000000000000141. PMID: 24901397.
Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol. 2008 Jul;27(3):326-32. doi: 10.1097/PGP.0b013e31815ea7f5. PMID: 18580309.
Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol. 2014 Nov;21(6):383-93. doi: 10.1097/PAP.0000000000000046. PMID: 25299308.
Fekete PS, Vellios F. The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases. Int J Gynecol Pathol. 1984;3(2):198-212. doi: 10.1097/00004347-198402000-00008. PMID: 6490315.
Evans HL. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer. 1982 Nov 15;50(10):2170-82. doi: 10.1002/1097-0142(19821115)50:10<2170::aid-cncr2820501033>3.0.co;2-k. PMID: 7127257.
Dionigi A, Oliva E, Clement PB, Young RH. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases. Am J Surg Pathol. 2002 May;26(5):567-81. doi: 10.1097/00000478-200205000-00003. PMID: 11979087.
ESMO / European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012 Oct;23 Suppl 7:vii92-9. doi: 10.1093/annonc/mds253. PMID: 22997462.
Shah JP, Bryant CS, Kumar S, Ali-Fehmi R, Malone JM Jr, Morris RT. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma. Obstet Gynecol. 2008 Nov;112(5):1102-8. doi: 10.1097/AOG.0b013e31818aa89a. PMID: 18978112.
Signorelli M, Fruscio R, Dell'Anna T, Buda A, Giuliani D, Ceppi L, Milani R. Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review. Int J Gynecol Cancer. 2010 Nov;20(8):1363-6. doi: 10.1111/IGC.0b013e3181efd861. PMID: 21051978.
Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003 Jun;89(3):460-9. doi: 10.1016/s0090-8258(03)00137-9. PMID: 12798712.
Sampath S, Schultheiss TE, Ryu JK, Wong JY. The role of adjuvant radiation in uterine sarcomas. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):728-34. doi: 10.1016/j.ijrobp.2009.02.077. Epub 2009 Aug 21. PMID: 19700247.
Reichardt P. The treatment of uterine sarcomas. Ann Oncol. 2012 Sep;23 Suppl 10:x151-7. doi: 10.1093/annonc/mds359. PMID: 22987952.
Biswas A, Patel F, Kumar P, Srinivasan R, Bera A, Sharma SC, Rajwanshi A. Uterine sarcoma-current management and experience from a regional cancer centre in North India. Arch Gynecol Obstet. 2013 Oct;288(4):873-82. doi: 10.1007/s00404-013-2843-7. Epub 2013 Apr 12. PMID: 23580012.
Sharma DN, Rath GK, Kumar S, Kumar L, Bhatla N, Gandhi AK, Hariprasad R. Clinical outcome of patients with uterine sarcomas. J Cancer Res Ther. 2011 Jul-Sep;7(3):270-4. doi: 10.4103/0973-1482.87011. PMID: 22044806.
Nusrath S, Bafna S, Rajagopalan R, Thammineedi SR, Raju KVVN, Patnaik SC, Pawar S, Reddy Y, Chavali RN, Murthy SS. Uterine Sarcomas: Experience from a Tertiary Cancer Care Center from India. Indian J Surg Oncol. 2019 Jun;10(2):342-349. doi: 10.1007/s13193-018-0860-5. Epub 2019 Jan 5. PMID: 31168260; PMCID: PMC6527712.
Lee CH, Mariño-Enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-Rychter M. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. The American journal of surgical pathology. 2012 May 1;36(5):641-53.
Oliva E, Carcangiu ML, Carinelli SG, et al. Mesenchymal tumours. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs, 4th edition. Lyon:IARC; 2014. 135-147
Davidson B, Kjæreng ML, Førsund M, Danielsen HE, Kristensen GB, Abeler VM. Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma. Am J Clin Pathol. 2016 Apr;145(4):449-58. doi: 10.1093/ajcp/aqw030. PMID: 27149024
Fletcher JA, Morton CC, Pavelka K, Lage JM. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. Cancer Res. 1990 Jul 1;50(13):4092-7. PMID: 2354458.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Bombay Hospital Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
